Skip to main content
Premium Trial:

Request an Annual Quote

As Expected, Orchid BioSciences Changes Name to Orchid Cellmark

NEW YORK, June 9 (GenomeWeb News) - Orchid BioSciences will change its name to Orchid Cellmark to reflect what the company said is its new emphasis on DNA-based identity testing, the company said today.


Orchid said that shareholders approved the name change at the Princeton, NJ-based company's annual stockholders meeting yesterday.

The new name would reference the Cellmark DNA testing services unit that Orchid acquired in 2001.


Orchid said in April it had planned to suggest the name change to shareholders this month.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.